Coagulopathy in transferred patients with massive hemorrhage

Coagulopathy in transferred patients with massive hemorrhage - Coagulopathy in transferred patients with massive hemorrhage

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041201

Enrollment

100

Registered

2020-08-01

Start date

2020-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

massive hemorrhage

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Massive hemorrhage was defined as follows: 1) systolic blood pressure <= 90 mmHg at the referring hospital 2) shock index (heart rate / systolic blood pressure) >= 1 at the referring hospital 3) in cases of maternal hemorrhage, cumulative blood loss >=1,000 ml or blood loss accompanied by signs or symptoms of hypovolemia 4) the judgement of the doctor from the referring hospital

Exclusion criteria

Exclusion criteria: patients who experienced cardiac arrest before arrival at our center

Design outcomes

Primary

Measure	Time frame
30-day mortality	—

Secondary

Measure	Time frame
coagulopathy at our center (coagulopathy was defined as fibrinogen value <= 150 mg/dl, or PT-INR >= 1.5) volume of blood products transfused	—

Countries

Japan

Contacts

Public ContactHiroyuki Takahashi

Teine Keijinkai Hospital Emergency and Critical Care Medical Center

htakahashi-tmd@umin.ac.jp011-681-8111

Outcome results